- Home
- APDN vs ENSC Comparison
APDN vs ENSC Comparison
Compare APDN & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APDN
- ENSC
- Stock Information
- Founded
- APDN 1983
- ENSC 2003
- Country
- APDN United States
- ENSC United States
- Employees
- APDN N/A
- ENSC N/A
- Industry
- APDN Other Consumer Services
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- APDN Consumer Discretionary
- ENSC Health Care
- Exchange
- APDN Nasdaq
- ENSC Nasdaq
- Market Cap
- APDN 4.2M
- ENSC 4.9M
- IPO Year
- APDN N/A
- ENSC N/A
- Fundamental
- Price
- APDN $4.50
- ENSC $2.28
- Analyst Decision
- APDN
- ENSC
- Analyst Count
- APDN 0
- ENSC 0
- Target Price
- APDN N/A
- ENSC N/A
- AVG Volume (30 Days)
- APDN 140.8K
- ENSC 64.8K
- Earning Date
- APDN 08-07-2025
- ENSC 08-13-2025
- Dividend Yield
- APDN N/A
- ENSC N/A
- EPS Growth
- APDN N/A
- ENSC N/A
- EPS
- APDN N/A
- ENSC N/A
- Revenue
- APDN $3,790,616.00
- ENSC $6,224,081.00
- Revenue This Year
- APDN $57.08
- ENSC N/A
- Revenue Next Year
- APDN $40.00
- ENSC $1,381.48
- P/E Ratio
- APDN N/A
- ENSC N/A
- Revenue Growth
- APDN N/A
- ENSC 256.35
- 52 Week Low
- APDN $4.37
- ENSC $1.62
- 52 Week High
- APDN $2,655.00
- ENSC $14.67
- Technical
- Relative Strength Index (RSI)
- APDN 35.16
- ENSC 53.77
- Support Level
- APDN $4.38
- ENSC $2.15
- Resistance Level
- APDN $5.10
- ENSC $2.34
- Average True Range (ATR)
- APDN 0.53
- ENSC 0.10
- MACD
- APDN 0.40
- ENSC 0.03
- Stochastic Oscillator
- APDN 22.32
- ENSC 90.63
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.